NOTE! 1. NFA (Not Financial Advice!) This is NOT a BUY or SELL advice. 2. Do NOT open position WITHOUT chart confirmation, indicators, momentum. 3. Scale out and secure profits. 4. Most importantly, DON’T BLAME ME for your losses. Your trade, your accountability. 5. I DO NOT give buy or sell advice 6 COH (cash on hand); AH (after hours): RTH (regular trading hours); PR (press release; FCF (free cash flow) 7. NEVER be a blind follower. 8. With regards t...
$Helius Medical Technologies (HSDT.US)$shortable shares has been at 0 since yesterday morning and the interest according to IBKR has gone up from 355% to 409% in the last couple hours 🧐
2
2
Report
5551212
:
let’s hope it can crawl back up above 1 soon
$Helius Medical Technologies (HSDT.US)$ NEWS1 : Bearish NEWS2: To cover the bearish factor usually companies will release some positive news not to dilute the investors NEWS1: today announced it has entered into agreements with certain holders of its existing warrants exercisable for 4,971,110 shares of its common stock, in the aggregate, to exercise outstanding warrants at a reduced exercise price of $0.751 per share. NEWS2: Helius Medical Announced Positive Results From The Pons Therapeutic Exp...
$Helius Medical Technologies (HSDT.US)$Wa.. this ticker up and down so fast.. like roller coaster.. try to sell but too slow down bavk again. Never mind , wait onr more round..
$Helius Medical Technologies (HSDT.US)$Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study 4 MINUTES AGO, 7:00 AM EST VIA GLOBENEWSWIRE
3
1
Report
JT99
:
seem like a controlled stock , with good news and yet got dump
$Helius Medical Technologies (HSDT.US)$ Helius Medical Technologies, Inc. Announces First Clinical Evidence of Positive Long-term Therapeutic Effects of PoNS Therapy® on Gait Deficit Improvement in Multiple Sclerosis from the PoNS® Therapeutic Experience Program Study Wednesday, 22nd January at 7:00 am --PoNS Therapeutic Experience Program (PoNSTEP) study demonstrates durable long-term beneficial effects of PoNS Therapy on gait deficit improvement in people with Multiple Sclerosis-- --Stati...
5551212 OP : slow run up
Mark Troy : The market will experience a sharp decline next week, everyone please take note and try to cash out as much as possible.